Correlation Between ENVVENO MEDICAL and Eli Lilly

Can any of the company-specific risk be diversified away by investing in both ENVVENO MEDICAL and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ENVVENO MEDICAL and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ENVVENO MEDICAL DL 00001 and Eli Lilly and, you can compare the effects of market volatilities on ENVVENO MEDICAL and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ENVVENO MEDICAL with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of ENVVENO MEDICAL and Eli Lilly.

Diversification Opportunities for ENVVENO MEDICAL and Eli Lilly

0.43

Correlation Coefficient

ENVVENO MEDICAL  Eli Lilly

Very weak diversification

The 3 months correlation between ENVVENO and Eli is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding ENVVENO MEDICAL DL 00001 and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and ENVVENO MEDICAL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ENVVENO MEDICAL DL 00001 are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of ENVVENO MEDICAL i.e., ENVVENO MEDICAL and Eli Lilly go up and down completely randomly.

Pair Corralation between ENVVENO MEDICAL and Eli Lilly

Assuming the 90 days horizon ENVVENO MEDICAL DL 00001 is expected to generate 2.24 times more return on investment than Eli Lilly. However, ENVVENO MEDICAL is 2.24 times more volatile than Eli Lilly and. It trades about 0.04 of its potential returns per unit of risk. Eli Lilly and is currently generating about 0.02 per unit of risk. If you would invest  252.00  in ENVVENO MEDICAL DL 00001 on December 20, 2024 and sell it today you would earn a total of  12.00  from holding ENVVENO MEDICAL DL 00001 or generate 4.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ENVVENO MEDICAL DL 00001  vs.  Eli Lilly and

ENVVENO MEDICAL DL

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ENVVENO MEDICAL DL 00001 are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, ENVVENO MEDICAL may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Eli Lilly

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Eli Lilly is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with ENVVENO MEDICAL and Eli Lilly

The main advantage of trading using opposite ENVVENO MEDICAL and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ENVVENO MEDICAL position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.

The idea behind ENVVENO MEDICAL DL 00001 and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.